ICAM-1 and CD36 are strong candidate receptors for interactions with iRBC containing mature Plasmodium parasites within the microvasculature at the time of sequestration, in both human infections and rodent model infections, and for the associated development of severe malaria pathologies. The gene discussed is CD36; the disease is infection.